No Data
No Data
Beyond Air Unit Receives Orphan Drug Designation for Prospective Phelan-McDermid Syndrome Treatment
12 Health Care Stocks Moving In Monday's After-Market Session
Beyond Air Shares Are Trading Higher After the Company Announced Its NeuroNOS Subsidiary Was Granted an FDA Orphan Drug Designation.
Express News | Beyond Air Shares Are Trading Higher After the Company Announced Its NeuroNOS Subsidiary Was Granted an FDA Orphan Drug Designation
Express News | Beyond Air Inc - Neuronos to Initiate First-in-Human Asd Trials in 2026
Express News | Neuronos Granted FDA Orphan Drug Designation for Phelan-Mcdermid Syndrome, a Neurodevelopmental Disorder Linked to Autism